Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Plusab Medical Solutions AB
AB
Dissolved
Org 5568489800
Omformargatan 18 A, 721 37
Västerås
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 15 years old
5-9 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Plusab Medical Solutions AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
40M
30M
20M
10M
0M
2020: 31M
31M
2020
2021: 31M (0% vs 2020)
31M
0%
2021
2022: 31M (0% vs 2021)
31M
0%
2022
2023: 32M (+3% vs 2022)
32M
+3%
2023
2024: 21M (-34% vs 2023)
21M
-34%
2024
EBITDA
SEK millions
6M
3M
0M
-2M
-5M
2020: 4M
4M
2020
2021: 3M (-25% vs 2020)
3M
-25%
2021
2022: 3M (0% vs 2021)
3M
0%
2022
2023: 3M (0% vs 2022)
3M
0%
2023
2024: -3M (-200% vs 2023)
-3M
-200%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
20 777
31 523
30 678
30 685
31 139
Staff expenses
—
—
—
—
—
EBITDA
−2 802
3 024
3 374
3 381
4 291
Depreciation & amort.
−95
−92
−43
−15
−28
EBIT
−2 897
2 932
3 331
3 366
4 263
Net financials
239
29
14
−2
−37
Profit before tax
−2 658
61
145
64
4 227
Tax
−0
−31
−87
−34
−917
Net profit
−2 658
30
58
30
3 310
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
8 479
12 031
15 068
12 150
12 051
Equity
6 077
8 735
8 704
8 646
8 616
Long-term debt
0
0
0
0
0
Short-term debt
2 183
3 296
6 363
3 504
3 435
Total debt
2 183
3 296
6 363
3 504
3 435
Financial ratios
5-year trend
EBITDA margin
-13.5%
This company
15.8%
Market median
This company
Market median
185% below market
2020
2024
Equity ratio
71.7%
This company
38.2%
Market median
This company
Market median
88% above market
2020
2024
Return on equity
-43.7%
This company
18.4%
Market median
This company
Market median
338% below market
2020
2024
Net profit margin
-12.8%
This company
8.1%
Market median
This company
Market median
258% below market
2020
2024
Asset turnover
2.45×
This company
1.12×
Market median
This company
Market median
119% above market
2020
2024
Debt / equity
0.40×
This company
0.62×
Market median
This company
Market median
35% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Plusab Medical Solutions AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
